Company news

TransMedics Group, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

February 11, 2024

TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 17, 2023

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference

November 13, 2023

TransMedics Reports Third Quarter 2023 Financial Results

November 5, 2023

TransMedics to Report Third Quarter 2023 Financial Results on November 6, 2023

October 22, 2023

TransMedics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 27, 2023

TransMedics Completes Acquisition of Summit Aviation

August 15, 2023

TransMedics Reports Second Quarter 2023 Financial Results

August 2, 2023

TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life

August 1, 2023

TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation

July 31, 2023

TransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference

July 25, 2023

TransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary

July 25, 2023

TransMedics to Report Second Quarter 2023 Financial Results on August 3, 2023

July 19, 2023

TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028

May 7, 2023

TransMedics Group, Inc. Announces Proposed Offering of $300 Million of Convertible Senior Notes Due 2028

May 7, 2023

TransMedics Reports First Quarter 2023 Financial Results

April 30, 2023

TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report

April 30, 2023

TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023

April 16, 2023

TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results

February 21, 2023

TransMedics to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023

February 7, 2023

TransMedics Appoints Nick Corcoran as Senior Vice President of Supply Chain and Operations

February 1, 2023

TransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

TransMedics Reports Third Quarter 2022 Financial Results

November 2, 2022

TransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022

October 19, 2022

TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

August 28, 2022

TransMedics Announces Upsize and Pricing of Public Offering of Common Stock

August 3, 2022

TransMedics Announces Proposed Public Offering of Common Stock

August 2, 2022

TransMedics Reports Second Quarter 2022 Financial Results

July 31, 2022

TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference

July 25, 2022

TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022

July 17, 2022

TransMedics Reports First Quarter 2022 Financial Results

May 2, 2022

TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication

April 27, 2022

TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022

April 18, 2022

TransMedics Announces the Presentation of New OCS™ Heart and OCS™ Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

April 18, 2022

TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference

February 28, 2022

TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

TransMedics to Present at the Cowen 42nd Annual Healthcare Conference

February 21, 2022

TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

February 8, 2022

TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery

January 4, 2022

TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference

December 21, 2021

TransMedics Reports Third Quarter 2021 Financial Results

November 8, 2021

TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

November 3, 2021

TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial

November 3, 2021

TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021

October 25, 2021

TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation

September 28, 2021

TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.­

September 6, 2021

TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

August 25, 2021

TransMedics Reports Second Quarter 2021 Financial Results

August 4, 2021

TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs

July 28, 2021

TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference

July 27, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.